VaxArray Coronavirus SeroAssay Kit v1.0 - Gateway Biosciences

VaxArray Coronavirus SeroAssay Kit v1.0

Accelerate coronavirus vaccine development by utilizing VaxArray’s rapid analytical platform to empower vaccine clinical efficacy studies, investigate population-level seroprevalence, or provide insight into vaccine manufacturing steps. SeroAssay kits used for detection and titer of coronavirus related antibodies from animal or human serum samples.

Each slide contains three antigens for SARS‐CoV‐2, one antigen for SARS‐CoV‐1, one antigen for MERS, and one antigen for each endemic coronavirus HKU1, OC43, 229E, and NL63. Each slide has 16 wells for analysis. Quantity 2 of detection label is needed for 4 slides.


4 slides

Cat#: VXCV‐5100


Coronavirus SeroAssay

  • 2 hours from samples to result. 30 minutes hands on time
  • Multiplexed analysis of current and past endemic strains
  • 100% Clinical Specificity and and 98.5% Clinical Sensitivity
  • Compatible with recombinant, peptide, VLP and other advanced vaccine technologies.
  • Evaluate serological samples from preclinical and clinical studies
  • Screen immunological profile of study participants against all human coronaviruses
  • Quantify vaccine immunogenicity
  • Confirm cross protection against 7 different coronaviruses
  • Research population level seroprevalence